# A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

> clinical trial · VERIFIED · 2026-07-17

Status: RECRUITING · Sponsor: Immunome, Inc. · Condition: Solid Malignancies

- Company: Immunome, Inc.
- Sector: Solid Malignancies
- Primary source: https://clinicaltrials.gov/study/NCT07505771

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.